Bone Stimulator for Spondylolysis
The Efficacy of Bone Stimulator in Treatment and Return-to-Sport for Spondylolysis
The Methodist Hospital Research Institute
48 participants
Dec 3, 2025
INTERVENTIONAL
Conditions
Summary
This prospective study aims to investigate the effectiveness of bone stimulator therapy as adjunct treatment of spondylolysis in athletic populations. By evaluating its impact on pain reduction, functional improvement, osseous bony union and return-to-sport time, the investigators seek to provide valuable insights into the role of bone stimulation therapy as a potential treatment modality for this challenging condition.
Eligibility
Inclusion Criteria3
- Patients between the ages of 16 to 40 years of age diagnosed with symptomatic spondylolysis by one of the investigators
- Patients who plan to attend prescribed physical therapy
- Patients who participate in a regular sport whether that be professional, collegiate or recreational
Exclusion Criteria8
- Any condition which in the investigator's opinion, would interfere with the subject's ability to comply with study instructions
- Patients with contraindications to bone stimulator therapy
- Patients with pacemaker and implantable cardioverter defibrillator
- Patients with previous spine surgery
- Patients with metabolic bone conditions
- Patients who use nicotine products
- Vulnerable populations
- Non-English speaking services
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Subjects will be asked to wear their device (if applicable) for a minimum of 30 minutes a day for 12 weeks with no maximum usage time. The device will track compliance. Bone stimulator should be worn at rest.
Participants will follow the standard of care regimen for spondylolysis treatment at Houston Methodist which will involve physical therapy and wearing a back brace.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06666608